Amgen gets the dirt flying on its new $550M manufacturing site as pharma building booms in NC
Amgen’s big, $1 billion investment in its manufacturing operations is officially underway, as the biotech broke ground on its Holly Springs, NC site Monday. The $550 million drug substance plant is one of two massive upgrades in the US for the California company, and it’s looking to capitalize on the region’s talented pool of potential employees.
Wake County and the Holly Springs local government awarded Amgen with job development grants worth $12.6 million and $22.8 million, respectively, contingent upon hiring milestones. Construction is scheduled to wrap up by 2029, though the plant will be operational in 2025. New hires will include engineers, technicians, quality, management and administrative staff. The average salary of the new positions added is expected to reach nearly $120,000, close to double what the current average is in Wake County. Another 350 jobs are expected to be added, upon the site’s completion.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.